Designer enzymes for glycosphingolipid synthesis by directed evolution.

Area of Science:

• Biochemistry
• Enzymology
• Synthetic Biology

Background:

• Glycosphingolipids show therapeutic promise for diseases like cancer, HIV, and autoimmune disorders.
• Current limitations in glycosphingolipid synthesis, particularly at scale, hinder their development as pharmaceuticals.
• Difficulties in synthesis impede extensive study of biological roles and drug development.

Purpose of the Study:

• To overcome synthetic limitations of glycosphingolipids by enhancing enzyme catalytic efficiency and substrate scope.
• To develop improved catalysts for facile and large-scale production of homogeneous glycosphingolipid samples.
• To demonstrate a generalizable approach for creating designer enzymes for glycosphingolipid synthesis.

Main Methods:

• Employed rational mutagenesis and directed evolution to modify a glycosphingolipid-synthesizing enzyme.
• Utilized an ELISA-based screening strategy to identify enzyme mutants with improved activity.
• Targeted both promiscuous substrate activity and overall catalytic efficiency of the enzyme.

Main Results:

• Identified several enzyme mutants exhibiting significantly enhanced catalytic activities.
• The engineered enzymes demonstrated the ability to produce a broad range of homogeneous glycosphingolipid samples.
• Successfully expanded the synthetic scope of the target enzyme.

Conclusions:

• The developed enzyme variants represent a significant advancement for facile, large-scale glycosphingolipid synthesis.
• This approach provides a powerful tool for creating designer enzymes tailored for specific glycosphingolipid production.
• The findings pave the way for broader therapeutic applications of glycosphingolipids.